DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUNC Lineberger Comprehensive Cancer Center
About this trial
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
Eligibility criteria
Qualifiers
Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
Age ≥ 60 years at the time of consent.
New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Preference Reporting to Improve Management and Experience (PRIME)
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
UNC Lineberger Comprehensive Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov